← Open Payments lookup

ERI HIROFUJI: Open Payments

NPI 1184099335 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$560 in 16 payments from 8 companies in 2025. Trend: 2023 $562 · 2024 $772 · 2025 $560

Food & beverage: $460Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.8$274
Astellas Pharma US Inc1$100
AstraZeneca Pharmaceuticals LP2$57
GlaxoSmithKline, LLC.1$29
Celgene Corporation1$28
Geron Corporation1$27
Rigel Pharmaceuticals, Inc.1$25
SOBI, INC1$20

Products named: RYBREVANT, CARVYKTI, TALVEY, CALQUENCE, BLENREP, REBLOZYL, RYTELO, TAVALISSE.

Industry payments across CA — which companies pay providers there.